1998
DOI: 10.1055/s-2006-957505
|View full text |Cite
|
Sign up to set email alerts
|

Prenylflavonoids: A New Class of Non-Steroidal Phytoestrogen (Part 2). Estrogenic Effects of 18-Isopentenylnaringenin on Bone Metabolism

Abstract: In order to examine whether 8-isopentenylnaringenin (1), which has been proven to possess estrogen agonist activity in in vitro tests, also produces in vivo estrogenic properties, the effects of 1 on uterus and on bone metabolism were determined in ovariectomized rats. Rats were ovariectomized and treated with 1 at 30 mg/kg/day subcutaneously for two weeks or 17 beta-estradiol at 0.01 mg/kg/day subcutaneously for two weeks. Ovariectomy resulted in an increase in urinary excretion of bone resorption markers (hy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
42
0

Year Published

2004
2004
2021
2021

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 63 publications
(43 citation statements)
references
References 7 publications
1
42
0
Order By: Relevance
“…Oral administration of compound 1 or 9 caused estrogenic effects in OVX SD rats by increasing their uterine weight, which was evaluated in OVX rats according to the method reported by Miyamoto et al 25) In contrast to the case of in vitro assays, compound 9 was more effective than genistein (1), which was reported to be converted to dihydrogenistein with less potent estrogenic activity by human intestinal microflora in the gastrointestinal tract. 26,27) However, compound 9 may be more resistant to degradation by intestinal bacteria due to the presence of a bulky 1,1-dimethylallyl group at C-8 in the A ring of the isoflavone skeleton, which may account for the more potent estrogenic activity of 9 in the in vivo experiment.…”
Section: Discussionmentioning
confidence: 99%
“…Oral administration of compound 1 or 9 caused estrogenic effects in OVX SD rats by increasing their uterine weight, which was evaluated in OVX rats according to the method reported by Miyamoto et al 25) In contrast to the case of in vitro assays, compound 9 was more effective than genistein (1), which was reported to be converted to dihydrogenistein with less potent estrogenic activity by human intestinal microflora in the gastrointestinal tract. 26,27) However, compound 9 may be more resistant to degradation by intestinal bacteria due to the presence of a bulky 1,1-dimethylallyl group at C-8 in the A ring of the isoflavone skeleton, which may account for the more potent estrogenic activity of 9 in the in vivo experiment.…”
Section: Discussionmentioning
confidence: 99%
“…For example, it inhibits the growth of human breast cancer cells in vitro, inhibits bone loss in ovariectomized mice (138), and inhibits the CYP1A2 cytochrome P450 involved in procarcinogen activation (73). It binds similarly to both ERα and ERβ, and its estrogenic activity in vitro is greater than that of genistein, daidzein, or coumestrol.…”
Section: Potential Health Beneficial Effectsmentioning
confidence: 99%
“…8-Prenylnaringenin (PN) is one of the most abundant prenylflavonoids in beer and has been reported to be a potent phyto-oestrogen in vitro (Stevens & Page, 2004). In a rat model 8-PN has been shown to inhibit ovariectomyinduced loss of BMD in the proximal tibia and suppress urinary excretion of the bone markers hydroxyproline, pyridinoline and deoxypyridinoline (Miyamoto et al 1998). 8-PN increases alkaline phosphatase activity in vitro in normal human fetal osteoblasts (0 .…”
Section: Prenylated Flavonoidsmentioning
confidence: 99%